- Home
- OLED vs NUVL Comparison
OLED vs NUVL Comparison
Compare OLED & NUVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OLED
- NUVL
- Stock Information
- Founded
- OLED 1985
- NUVL 2017
- Country
- OLED United States
- NUVL United States
- Employees
- OLED N/A
- NUVL N/A
- Industry
- OLED Semiconductors
- NUVL Biotechnology: Pharmaceutical Preparations
- Sector
- OLED Technology
- NUVL Health Care
- Exchange
- OLED Nasdaq
- NUVL Nasdaq
- Market Cap
- OLED 7.1B
- NUVL 7.1B
- IPO Year
- OLED 1992
- NUVL 2021
- Fundamental
- Price
- OLED $114.27
- NUVL $107.41
- Analyst Decision
- OLED Buy
- NUVL Strong Buy
- Analyst Count
- OLED 6
- NUVL 13
- Target Price
- OLED $181.33
- NUVL $133.85
- AVG Volume (30 Days)
- OLED 635.7K
- NUVL 748.1K
- Earning Date
- OLED 11-06-2025
- NUVL 10-30-2025
- Dividend Yield
- OLED 1.58%
- NUVL N/A
- EPS Growth
- OLED N/A
- NUVL N/A
- EPS
- OLED 4.64
- NUVL N/A
- Revenue
- OLED $639,977,000.00
- NUVL N/A
- Revenue This Year
- OLED $6.78
- NUVL N/A
- Revenue Next Year
- OLED $10.92
- NUVL N/A
- P/E Ratio
- OLED $24.53
- NUVL N/A
- Revenue Growth
- OLED N/A
- NUVL N/A
- 52 Week Low
- OLED $103.70
- NUVL $55.54
- 52 Week High
- OLED $173.45
- NUVL $112.88
- Technical
- Relative Strength Index (RSI)
- OLED 33.19
- NUVL 63.64
- Support Level
- OLED $107.23
- NUVL $93.05
- Resistance Level
- OLED $121.42
- NUVL $112.88
- Average True Range (ATR)
- OLED 5.38
- NUVL 5.51
- MACD
- OLED -1.80
- NUVL 0.94
- Stochastic Oscillator
- OLED 18.15
- NUVL 75.57
About OLED Universal Display Corporation
Universal Display Corp researches, develops, and manufactures organic light-emitting diode, or OLED, technologies for use in displays for mobile phones, tablets, televisions, wearables, personal computers, automotive interiors, and the solid-state lighting market. OLED technologies are an alternative to light-emitting diode, or LED, technologies, in the solid-state lighting market, and liquid crystal displays in the flat-panel-display market. The Company has one reportable business segment being OLED technologies and materials. A large majority of the firm's revenue is generated in South Korea, with the rest coming from Japan, China, the United States, and other countries across the world.
About NUVL Nuvalent Inc.
Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of the Company's operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically validated kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.